Thai Cancer Anemia Survey in Chulalongkorn Hospital

Completed

• Conditions: Cancer; Anemia

• Registration Number: NCT01018043
• Lead Sponsor: Janssen-Cilag Ltd.,Thailand

Brief Summary

The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.

Detailed Description

Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemoglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered

Study Timeline

• Study Start: 2006-04
• Study First Submitted: 2009-11-19
• Study First Submitted QC: 2009-11-20
• Study First Posted: 2009-11-23
• Primary Completion: 2009-12
• Study Completion: 2009-12
• Status Verified: 2014-05
• Last Update Submitted: 2014-05-22
• Last Update Posted: 2014-05-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 264

Inclusion Criteria

• Patients with cancer

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of patients that have anemia during cancer therapy	6 months

Secondary Outcome Measures

Name	Time	Method
Characteristic of each patients example treatment duration,type and chemotherapy using, grade of anemia	6 months